Sachin S. Lawande - 04 Mar 2026 Form 4 Insider Report for VISTEON CORP (VC)

Signature
Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Sachin S. Lawande
Issuer symbol
VC
Transactions as of
04 Mar 2026
Net transactions value
-$4,620,762
Form type
4
Filing time
05 Mar 2026, 16:20:15 UTC
Previous filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lawande Sachin CEO and President, Director VISTEON CORPORATION, ONE VILLAGE CENTER DRIVE, VAN BUREN TOWNSHIP Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Sachin S. Lawande 05 Mar 2026 0001454378

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VC Common Stock Options Exercise +49,453 +28% $80.97* 224,980 04 Mar 2026 Direct F1, F2
transaction VC Common Stock Sale $2,350,277 -25,299 -11% $92.90 199,681 04 Mar 2026 Direct F3
transaction VC Common Stock Sale $1,679,335 -17,911 -9% $93.76 181,770 04 Mar 2026 Direct F4
transaction VC Common Stock Sale $591,150 -6,243 -3.4% $94.69 175,527 04 Mar 2026 Direct F5
holding VC Common Stock 146,229 04 Mar 2026 By SLAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VC Employee Stock Option (right to buy) Options Exercise -49,453 -100% $0.000000* 0 04 Mar 2026 Common Stock 49,453 $80.97 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2025.
F2 The options will expire if not exercised prior to March 6, 2026.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.37 - $93.36, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.37 - $94.36, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 - $95.13, inclusive.
F6 The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.